Evaluation of effect of the primary particle size on compactibility of spray-dried lactoses

Spray-dried lactose is one of the most used filler-binders in direct compaction of tablets. Spray-dried lactose is produced by spray-drying a suspension of α-lactose monohydrate crystals in a saturated aqueous solution of lactoses. The resulting product is composed of spherical particles, containing 80-85% crystals of α-lactose monohydrate (primary particles) and 15-20% amorphous lactose The compactibility of two commercial spray-dried lactoses, Pharmatose® DCL 11 (DCL11), prepared from α-lactose monohydrate with a median primary particle size of 34 µm and a new product, Pharmatose® DCL 14 (DCL14), prepared from 20 µm primary particles, were investigated

Design and evaluation of dry-coated tablets for colonic delivery of diclofenac sodium

A colonic drug delivery system is required to protect a drug during its transit through the upper gastro-intestinal tract and allow its release in the colon. The aim of this study was the preparation of dry-coated tablets designed for colonic release of the model drug Diclofenac sodium (DS). The system consists of a drug-pectine (PC) mixture as the core and hydroxypropylmethylcellulose (HPMC) alone or mixed in different ratios with poly(ε-caprolactone) (CL) as the coat layer

Study of dissolution rate enhancement of poorly water soluble drug

Aim of this work is the preparation of spray-dried microspheres as drug delivery systems for Rokitamycin (RK), using chitosan (C) and its salt, chitosan glutamate (CG) to improve the dissolution rate of the drug. The work further aimed to investigate the effect of the type of chitosan and feed solution concentration on the microsphere properties

<i>In vitro</i> and <i>in vivo</i> studies of artichoke extract (<i>Cynara scolymus</i> L.) as ketoprofen skin penetration enhancer

In this study, the enhancing effect of artichoke extract containing cynaropicrin on the in vitro and in vivo percutaneous absorption of ketoprofen from gels has been investigated

Improvement of antiamoebic activity of Rokitamycin loaded in chitosan microspheres

Rokitamycin is a new macrolide containing 16 carbon atoms, strongly inhibitory for Acanthamoeba castellanii, an opportunistic protozoa of humans which cause primarily amoebic keratitis and chronic, but fatal, amoebic granulomatous meningoencephalitis. Chitosan microspheres were prepared as carriers to obtain a controlled release of rokitamycin, able to improve the antiamoebic activity of this drug. The microparticles were in vitro characterised and the efficacy of rokitamycin alone and encapsulated into microspheres on the growth rate of Acanthamoeba castellani was evaluated. The results obtained suggest that spray-drying is a good technique for the preparation of microspheres loaded with rokitamycin. The loading of the drug into the polymeric network leads to an increase in the dissolution rate compared to drug raw material and improves and prolongs the in vitro antiamoebic activity of the drug. Thus, microspheres based on rokitamycin could be used in the therapy of systemic and topical infections caused by Acanthamoeba

Nanoparticles based on hydroxypropylcyclodextryn: preparation and in vitro viability study on Caco2 cells

The work purpose was to prepare and in vitro characterise solid nanoparticles based on hydroxypropyl-β-cyclodextrin (HP) by high pressure emulsification method; the effect on the viability of the formulations on Caco2 cells has been also evaluated

Spray-dried microspheres based on methylpyrrolidinone chitosan: <i>in-vitro</i> and <i>ex-vivo</i> studies

The purpose of this work was the preparation and the study of methypyrrolidinone chitosan spray-dried microspheres for the intranasal release of metoclopramide hydrochloride (Met). Chitosan (CH) microparticles were prepared as comparison

Bio-inspired apatite particles limit skin penetration of drugs for dermatology applications

Most treatments of skin pathologies involve local administration of active agents. One issue can however be the partial transcutaneous diffusion of the drug to blood circulation, leading to undesirable effects. In this work, the original use of submicron mineral particles based on bio-inspired calcium phosphate apatite was explored for the first time as drug carriers for favoring topical delivery. The permeation of a model drug across synthetic and biological membranes was investigated in both static and dynamic conditions. Our data show that adsorption of the drug on the apatite particles surface drastically limits its permeation, with lower effective diffusion coefficients (Peff) and smaller total released amounts. The retention of the apatite colloidal particles on porcine ear skin explants surface was demonstrated by combining histological observations and Raman confocal microscopy. All results converge to show that association of the drug to apatite particles favors skin surface effects. These findings point to the relevance of mineral-based particles as drug carriers for local delivery to the skin, and open the way to novel applications of bio-inspired apatites in dermatology. Statement of Significance Calcium phosphates (CaP) are major biomaterials in orthopedics and dentistry. Their resemblance to bone mineral allows new applications beyond bone repair, e.g. in nanomedicine. In 2018, a 14-page detailed review (M. Epple, Acta Biomaterialia 77 (2018) 1–14) provided clear facts in favor of the non-toxicity of nanosized CaP as an answer to discussions from EU and US study groups, thus clarifying the path to novel applications of nano CaP. In the present paper, bio-inspired apatite nanoparticles are used for the first time as drug carriers for dermatology for drastically limiting drug transcutaneous permeation and retaining a topical effect. We demonstrate this proof of concept via permeation cell tests, histology, Raman microscopy and photoluminescence after application on porcine ear skin